Health
New antiviral repurposing study finds peptides that could prevent SARS-CoV-2-ACE2 binding – News-Medical.Net
A new study reports the antiviral potential of peptides against SARS-CoV-2’s spike protein.
As the world continues to struggle with the coronavirus disease 2019 (COVID-19) pandemic, researchers are busy searching for pharmaceuticals that can effectively counteract the pathogen. This causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), infects through engagement via its spike protein with the host cell, attaching to the angiotensin-converting enzyme 2 (ACE2) receptor. The spike-ACE2 interaction has thus become a prime target of antiviral strategies.
A new study…
-
Business23 hours agoprofit up 7%, guidance strong
-
Noosa News16 hours agoFollowing Up Hottest 100 of Australian Songs Success with a Second Documentary About Your Life and Career: Jimmy Barnes Talks ‘Working Class Man’
-
Noosa News21 hours agoItalian Film Festival, Brisbane: All the Details
-
Noosa News16 hours agoKatter and pregnant wife crash-land plane in outback Qld